JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,776 | -25.8% | 13,073 | -12.6% | 0.00% | – |
| Q2 2023 | $177,480 | -15.4% | 14,952 | -13.7% | 0.00% | – |
| Q1 2023 | $209,705 | +132.4% | 17,331 | +153.0% | 0.00% | – |
| Q4 2022 | $90,228 | -1.9% | 6,851 | +1.1% | 0.00% | – |
| Q3 2022 | $92,000 | +2.2% | 6,774 | -7.7% | 0.00% | – |
| Q2 2022 | $90,000 | -17.4% | 7,338 | -3.2% | 0.00% | – |
| Q1 2022 | $109,000 | -22.7% | 7,579 | +6.0% | 0.00% | – |
| Q4 2021 | $141,000 | -9.0% | 7,149 | 0.0% | 0.00% | – |
| Q3 2021 | $155,000 | – | 7,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |